digitalis: be beneficial to patients

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents plant
Weight: 0.37
Siblings aloe vera
Weight: 0.29
, valerian
Weight: 0.29
, chrysanthemum
Weight: 0.29
, horsetail
Weight: 0.28

Related properties

Property Similarity
be beneficial to patients 1.00
be beneficial to patients in heart failure 0.90
be given to patients 0.88
be given to patients with heart failure 0.80

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Salient implies Plausible

0.19
Rule weight: 0.28
Evidence weight: 0.69
Similarity weight: 1.00
Evidence: 0.60
Plausible(digitalis, be beneficial to patients)
Evidence: 0.77
¬ Salient(digitalis, be beneficial to patients)

Similarity expansion

0.73
Rule weight: 0.85
Evidence weight: 0.95
Similarity weight: 0.90
Evidence: 0.80
Remarkable(digitalis, be beneficial to patients)
Evidence: 0.24
¬ Remarkable(digitalis, be beneficial to patients in heart failure)
0.72
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.90
Evidence: 0.77
Salient(digitalis, be beneficial to patients)
Evidence: 0.26
¬ Salient(digitalis, be beneficial to patients in heart failure)
0.69
Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.88
Evidence: 0.80
Remarkable(digitalis, be beneficial to patients)
Evidence: 0.44
¬ Remarkable(digitalis, be given to patients)
0.66
Rule weight: 0.85
Evidence weight: 0.97
Similarity weight: 0.80
Evidence: 0.80
Remarkable(digitalis, be beneficial to patients)
Evidence: 0.14
¬ Remarkable(digitalis, be given to patients with heart failure)
0.66
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.90
Evidence: 0.60
Plausible(digitalis, be beneficial to patients)
Evidence: 0.33
¬ Plausible(digitalis, be beneficial to patients in heart failure)
0.66
Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.88
Evidence: 0.77
Salient(digitalis, be beneficial to patients)
Evidence: 0.52
¬ Salient(digitalis, be given to patients)
0.66
Rule weight: 0.85
Evidence weight: 0.96
Similarity weight: 0.80
Evidence: 0.77
Salient(digitalis, be beneficial to patients)
Evidence: 0.17
¬ Salient(digitalis, be given to patients with heart failure)
0.63
Rule weight: 0.85
Evidence weight: 0.92
Similarity weight: 0.80
Evidence: 0.60
Plausible(digitalis, be beneficial to patients)
Evidence: 0.21
¬ Plausible(digitalis, be given to patients with heart failure)
0.58
Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.88
Evidence: 0.60
Plausible(digitalis, be beneficial to patients)
Evidence: 0.54
¬ Plausible(digitalis, be given to patients)
0.58
Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.90
Evidence: 0.53
Typical(digitalis, be beneficial to patients)
Evidence: 0.51
¬ Typical(digitalis, be beneficial to patients in heart failure)
0.53
Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.80
Evidence: 0.53
Typical(digitalis, be beneficial to patients)
Evidence: 0.48
¬ Typical(digitalis, be given to patients with heart failure)
0.53
Rule weight: 0.85
Evidence weight: 0.70
Similarity weight: 0.88
Evidence: 0.53
Typical(digitalis, be beneficial to patients)
Evidence: 0.63
¬ Typical(digitalis, be given to patients)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.90
Similarity weight: 1.00
Evidence: 0.77
Salient(digitalis, be beneficial to patients)
Evidence: 0.53
¬ Typical(digitalis, be beneficial to patients)
Evidence: 0.80
¬ Remarkable(digitalis, be beneficial to patients)

Typical implies Plausible

0.38
Rule weight: 0.48
Evidence weight: 0.79
Similarity weight: 1.00
Evidence: 0.60
Plausible(digitalis, be beneficial to patients)
Evidence: 0.53
¬ Typical(digitalis, be beneficial to patients)